US Stock MarketDetailed Quotes
EVAX Evaxion Biotech
- 1.140
- -0.050-4.20%
Close Dec 13 16:00 ET
- 1.100
- -0.040-3.51%
Post 17:58 ET
6.69MMarket Cap-0.41P/E (TTM)
1.220High1.090Low82.29KVolume1.150Open1.190Pre Close95.49KTurnover2.24%Turnover RatioLossP/E (Static)5.87MShares13.61052wk High87.69P/B4.19MFloat Cap1.08052wk Low--Dividend TTM3.67MShs Float250.400Historical High--Div YieldTTM10.92%Amplitude1.080Historical Low1.160Avg Price1Lot Size
About Evaxion Biotech Company
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen M?ller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
Company Profile
SymbolEVAX
Company NameEvaxion Biotech
Listing DateFeb 5, 2021
Issue Price10.00
Founded2008
CEOMr. Christian Kanstrup
MarketNASDAQ
Employees49
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends12-31
AddressDr. Neergaards Vej 5F
CityHoersholm
ProvinceNorth Denmark
CountryDenmark
Zip Code2970
Phone45-53-53-18-50
Company Executives
- Name
- Position
- Salary
- Christian Kanstrup
- Chief Executive Officer
- --
- Birgitte Rono
- Chief Scientific Officer
- --
- Jesper Nyegaard Nissen
- Chief Operating Officer and Chief Financial Officer
- --
- Andreas Holm Mattsson
- Chief AI and Culture Officer
- --
- Marianne Sogaard
- Chairman of Board
- 163.00K
- Dr. Niels Iversen Moller
- Director
- 74.00K
- Roberto Prego
- Independent Director
- 63.00K
- Lars Holtug
- Independent Director
- 59.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data